XRTX
XORTX Therapeutics·NASDAQ
--
--(--)
--
--(--)
6.86 / 10
Outperform
Fund-flow analysis is the most encouraging, with a 6.86/10 score and good sentiment. Small and Medium inflow ratios are above 0.50, indicating buying interest in smaller orders, while large-block flows are mixed. Although overall fund trend is negative, the positive liquidity momentum provides a counterbalance to the weak fundamentals and technicals.
Fund Flow Rating
Is money flowing into or out of XRTX?
- XRTX holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.86/10 (Outperform).
